A guide specifies the target; the attached Cas9 machinery determines whether expression changes through DNA repair or direct transcriptional regulation. In CRISPR genome editing, a guide RNA supplies sequence complementarity to a genomic target adjacent to a suitable protospacer adjacent motif. The commonly used Cas9 from Streptococcus pyogenes recognizes an NGG motif, where N is any base. Recognition involves both that motif and pairing between the guide and target DNA; an arbitrary complementary sequence is therefore insufficient. In mammalian experiments, a nuclear-localized Cas9 and guide can be delivered by expression constructs or as a preassembled ribonucleoprotein. Multiplexing means supplying several guides, rather than engineering a new DNA-binding protein for every target. The original mammalian demonstration combined programmable targeting with endogenous repair to change genomic sequences.[ref]
For a loss-of-function experiment, a cut in an early constitutive exon is repaired by non-homologous end joining and related end-joining pathways. Insertions or deletions can change the reading frame, introduce a premature stop, and trigger nonsense-mediated decay. Neither cleavage nor an insertion/deletion automatically proves a gene knockout: repair can preserve the reading frame, alternative splicing can bypass the exon, and a mammalian cell may retain an intact allele. Targeting a promoter or enhancer can instead alter the amount or cell specificity of expression. Two guides can delete a defined regulatory segment, but the resulting junction and possible larger rearrangements need verification. homology-directed repair with a donor can introduce an expression tag, repair a mutation, or replace a regulatory sequence; its efficiency depends on cell state and competing repair pathways. Changing the genomic coding sequence can change protein activity without changing transcript abundance, so these outcomes should be distinguished.
Expression can also be controlled without cleavage. Catalytically inactive dCas9 retains guide-directed binding. Positioning it at an appropriate regulatory region can obstruct transcription; recruiting a repressive domain such as KRAB strengthens CRISPR interference in mammalian cells. Fusing an activation domain, or recruiting several activators, gives CRISPR activation at an endogenous promoter. These approaches preserve the coding sequence and permit graded or inducible perturbation, although chromatin context and guide position strongly affect performance. Mammalian experiments comparing regulatory fusions established that the same targeting platform can repress or activate transcription.[ref]
The readout should match the proposed mechanism: sequence the target for editing, measure messenger RNA by RT-qPCR, and measure the protein and its biological activity. Use multiple independent guides, a nontargeting guide, delivery-matched controls, and several independently derived clones or a controlled pooled experiment. Rescue with a guide-resistant functional gene supports causality; overexpression rescue alone can have dosage artefacts. Check relevant predicted off-target effects, assess cell viability, and distinguish direct expression changes from selection of surviving cell states. A nuclease perturbation can itself activate a DNA-damage response. Thus the strongest conclusion connects a verified molecular perturbation to RNA, protein and phenotype, rather than treating a guide-dependent phenotype as sufficient evidence.
PCR converts a selected DNA sequence into a detectable and manipulable quantity; different downstream measurements give it different uses. A pair of PCR primers defines the interval amplified by DNA polymerase. Repeated denaturation, annealing and extension produce approximately copies while PCR efficiency remains constant. At ideal efficiency, twenty cycles give about a millionfold amplification; depletion and accumulating products eventually cause a PCR plateau. Specificity derives from both primer-binding sites and their orientation, and should be checked by product size, melting behaviour or sequencing.
One application is genotyping. A disease-associated substitution can be detected by amplifying the surrounding region and reading the sequence, probing with an allele-specific oligonucleotide, or digesting a restriction site changed by the variant. An early demonstration amplified the human beta-globin region for restriction-based diagnosis of sickle cell disease. Amplification increased sensitivity; the restriction pattern supplied the allele information.[ref] A negative disease-specific signal is interpretable only if a control locus amplifies, because poor extraction or an inhibitor can mimic absence of an allele. In forensic DNA profiling, several short tandem repeat loci are amplified and fragment lengths compared. A multilocus match supports identity statistically; it does not eliminate contamination, mixtures, allelic dropout or the need for appropriate population-frequency estimates.
For infectious agents, primers can detect a pathogen-specific DNA sequence. An RNA virus first requires reverse transcription, followed by polymerase chain reaction. In RT-qPCR, fluorescence is monitored during amplification, and a threshold cycle is related to starting RNA using calibrated standards and efficiency measurements. This also measures changes in cellular gene expression: compare a target transcript between conditions after suitable normalization. Include extraction controls, a no-template reaction and, for RNA measurements, a no-reverse-transcriptase control to detect genomic DNA contamination. A positive pathogen signal establishes the presence of target nucleic acid, not necessarily a viable organism or infectious virus. Likewise, RNA abundance is not a direct measurement of protein abundance or transcription rate, since RNA degradation also matters.
PCR is also a preparative method. Amplified coding sequences can be assembled into expression vectors; primer tails can add restriction sites, assembly overlaps, sequencing adaptors or an affinity tag. High-fidelity polymerase reduces unwanted substitutions, but the final clone should still be sequenced. Site-directed mutagenesis introduces a specified substitution using mutagenic primers, whereas error-prone PCR creates a library for directed evolution. Sequencing after selection distinguishes the intended change from other mutations. In chromatin immunoprecipitation, quantitative amplification of recovered loci can test enrichment of a DNA-associated protein, with input DNA and immunoprecipitation controls needed to interpret it.
These examples separate presence, identity, quantity and construction. Endpoint band intensity is a poor substitute for quantitative amplification measured before the PCR plateau; multiplex assays can also suffer unequal amplification. The appropriate answer therefore identifies what is amplified, what is measured, and which alternative explanation each control excludes.
Strong lac expression requires relief of lactose-responsive repression together with a favourable glucose-responsive activation state. In Escherichia coli, the lac operon encodes beta-galactosidase, lactose permease and a transacetylase. LacI binds operator DNA and represses transcription; binding of the inducer allolactose shifts its conformation and reduces operator occupancy. Basal expression provides enough permease and beta-galactosidase to import and process some lactose, including formation of allolactose. This explains induction without requiring a completely silent system somehow to manufacture its own detector.
Glucose availability affects positive regulation. When glucose is scarce, the physiological state of the phosphotransferase system favours activation of adenylate cyclase and increased cyclic AMP. Binding of cyclic AMP activates catabolite activator protein, also called CRP, which binds near the lac promoter and helps recruit RNA polymerase. In glucose-rich conditions this activation is reduced. Operator repression and activator-dependent recruitment act at distinct sites, so relief of repression does not guarantee maximum expression. The promoter behaves approximately as a requirement for lactose availability AND glucose scarcity, but its quantitative output is graded rather than a perfect digital gate.
Glucose also regulates inducer entry. During glucose uptake through the phosphotransferase system, the glucose-specific EIIA glucose protein tends to be dephosphorylated. That form can bind and inhibit lactose permease, reducing lactose entry and hence allolactose formation. This inducer exclusion reinforces repression while a preferred substrate is being used. Mutations in the central cytoplasmic loop of the permease that abolish regulation and binding provide a way of separating transport inhibition from promoter regulation.[ref] It is therefore incomplete to attribute every glucose effect to cyclic AMP alone.
The four limiting conditions make the integration clear. Without lactose, LacI represses whether glucose is high or low; an active CRP cannot simply substitute for inducer. With lactose and abundant glucose, induction is limited by weak activation and often by inducer exclusion. With lactose and little glucose, repression is relieved and CRP-dependent recruitment is favoured, giving the highest expression. With both sugars initially available, glucose consumption followed by adaptation to lactose can produce diauxic growth; the timing depends on concentrations, transport and culture conditions.
Genetic and physiological controls distinguish the mechanisms. A loss-of-function LacI mutation should remove inducer dependence and can be complemented by a functional repressor supplied in trans. An operator mutation acts primarily in cis, on the linked operon. A superrepressor that cannot respond appropriately to inducer can remain repressive despite lactose. Compare promoter reporters and lactose-uptake measurements separately, because an uptake defect and a transcription defect can give similar growth phenotypes. Adding cyclic AMP tests one activation arm, but cannot necessarily overcome a permease blocked by inducer exclusion. The cell combines a local substrate signal with a global carbon-use signal, acting through both transcription and transport.

Articles by others on the same topic (0)

There are currently no matching articles.